Recent advances in biomolecular medicine and biotechnology will make it possible for the injured brain to regenerate.

Uses of NCQA quality measures extends to 60% of US population

Social activity model shows COVID-19 will be endemic, sticking around like the flu and the common cold

The Rome Foundation Research Institute and Danone Nutricia Research have partnered on a study to look at the prevalence of bloating and distension in patients diagnosed with irritable bowel syndrome (IBS) or functional dyspepsia (FD).

Biopharmaceutical research company leverages positive data on its cannabinoid-containing mixtures to develop new cytokine release syndrome therapies

Patients can now receive a diagnosis of IBS or other disorders of gut-brain interaction and begin treatment sooner through use of this criteria designed only for clinical use.

Dr. Kenton specializes in non-invasive cardiology, internal medicine, and wellness.

Ability to negotiate prices for certain drugs - a coming victory for Medicare Users

Thirty-three Navy SEAL veterans were treated with a bone marrow mesenchymal stem cell (MSC) derived extracellular vesicle isolate product (EVIP) for Osteoarthritis (OA) of the knee, shoulder, elbow, hip, ankle, or wrist.

The Iowa-based 22-Location Mission Cancer + Blood Joins QCCAN's Rapidly Growing Clinically Integrated National Network

Drug Price Regulation and Additional Factors Create 65% Savings on Drug Costs

Accuhealth's award winning remote patient monitoring platform is now available in the Epic App Orchard

Studies offer insight into who might benefit from interferon for treatment of a rare blood cancer

Hyris developed a rapid T-Cell test to track patients' immunity levels to SARS-CoV-2 for global clinical and research use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the power of the renowned HYRIS bCUBE™ and the whole Hyris SystemTM. This disruptive platform enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.

Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.

"Rare" is a film exploring the world of rare diseases and the unsung heroes pushing for medical breakthroughs.

Next Level Urgent Care Advances COVID-19 Research, Therapeutic Options for both Treatment and Prevention

Free educational webinar hosted by Hardy Diagnostics offered with continuing education credits

International Pharmacies in Canada and Elsewhere Able to Dispense Rx Meds for Less

Highlighting Gb Sciences' Development of Plant-Inspired Therapies for COVID-related Cytokine Release Syndrome, Chronic Pain, and Parkinson's Disease during the Healthcare & Biotech Track starting Monday, September 13.

GreenMark™ Biomedical Inc. announced the company has been selected as a 2021 Cellerant Best of Class Technology Award recipient.

San Francisco Dental Implant Center announces a new post about the value of meeting with a highly rated dental implant doctor. A specialist in San Francisco may be the best choice for oral surgery.